Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults

Crescenzo F De; Liliya Eugenevna Ziganshina; Ekaterina V. Yudina; Yusuf Cem Kaplan; Marco Ciabattini; Yinghui Wei; Charles H.V. Hoyle

doi:10.1002/14651858.cd013044

Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults

Crescenzo F De, Liliya Eugenevna Ziganshina^*, Ekaterina V. Yudina, Yusuf Cem Kaplan, Marco Ciabattini, Yinghui Wei, Charles H.V. Hoyle

^*Corresponding author for this work

School of Engineering, Computing and Mathematics

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	0
Journal	Cochrane Database of Systematic Reviews
Volume	0
Issue number	0
DOIs	https://doi.org/10.1002/14651858.cd013044
Publication status	E-pub ahead of print - 7 Jun 2018

Access to Document

10.1002/14651858.cd013044

Cite this

@article{6c86b416e78446f180729b1cf1a4c847,

title = "Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults",

author = "De, {Crescenzo F} and Ziganshina, {Liliya Eugenevna} and Yudina, {Ekaterina V.} and Kaplan, {Yusuf Cem} and Marco Ciabattini and Yinghui Wei and Hoyle, {Charles H.V.}",

year = "2018",

month = jun,

day = "7",

doi = "10.1002/14651858.cd013044",

language = "English",

volume = "0",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "0",

}

TY - JOUR

T1 - Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults

AU - De, Crescenzo F

AU - Ziganshina, Liliya Eugenevna

AU - Yudina, Ekaterina V.

AU - Kaplan, Yusuf Cem

AU - Ciabattini, Marco

AU - Wei, Yinghui

AU - Hoyle, Charles H.V.

PY - 2018/6/7

Y1 - 2018/6/7

U2 - 10.1002/14651858.cd013044

DO - 10.1002/14651858.cd013044

M3 - Article

SN - 1465-1858

VL - 0

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 0

ER -